References
- Newsom-Davis J, Buckley C, Clover L, Hart I, Maddison P, TüzümE, . Autoimmune disorders of neuronal potassium channels. Ann NY Acad Sci. 2003;998:202–10.
- Chio A, Brignolio F, Meineri P, Rosso MG, Tribolo A, Schiffer D. Motor neuron disease and malignancies: results of a population-based study. J Neurol. 1988;235:374–5.
- Freedman DM, Travis LB, Gridley G, Kuncl RW. Amyo-trophic lateral sclerosis mortality in 1. 9 million US cancer survivors. Neuroepidemiology. 2005;25:176–80.
- Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, . Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38:714–22.
- Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Verma A, Berger J, Snodgrass S, Petito C. Motor neuron disease: a paraneoplastic process with anti-Hu antibody and small-cell lung carcinoma. Ann Neurol. 1996;40:112–6.
- Khawaja S, Sripathi N, Ahmad BK, Lennon V. Paraneoplastic motor neuron disease with type 1 purkinje cell antibodies. Muscle Nerve. 1998;21:943–5.
- Lavrnic D, Vidakovic A, Miletic V, Trikic R, Marinkovic Z, Rakocevic V, . Motor neuron disease and monoclonal gammopathy. Eur Neurol. 1995;35:104–7.
- Pestronk A, Adams RN, Clawson L, Cornblath D, Kunel RW, Griffin D, . Serum antibodies to GM1 gan-glioside in amyotrophic lateral sclerosis. Neurology. 1988; 38:1457–61.
- Sanders KA, Rowland LP, Murphy PL, Younger DS, Latov N, Sherman WH, . Motor neuron diseases and amyotrophic lateral sclerosis: GM1 antibodies and parapro-teinemia. Neurology. 1993;43:418–20.
- Mzutani K, Oka N, Kusunki S, Kaji R, Kanda M, Akiguchi I, . Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Internal Medicine. 2003;43: 277–80.
- Appel SH, Smith RG, Engelhardt JI, Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci. 1993;188:169–74.
- Drachman DB, Chaudhry V, Cornblath D, Kuncl RW, Pestronk A, Clawson L, . Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Ann Neurol. 1994;35:142–50.
- Tan E, Lynn J, Amato AA, Kissell JT, Rammohan KW, Sahenk Z, . Immunosuppressive treatment of motor syndromes. Arch Neurol. 1994;51:194–200.
- Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltage gated potassium channel autoimmunity. Neurology. 2008;70:1883–90.
- Vincent A, Buckley C, Schott J, Baker I, Dewar B, Detert N, . Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701–12.
- Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyper-excitability. Muscle Nerve. 2002;26:702–7.